Jinqian Liu

1.4k total citations
29 papers, 1.1k citations indexed

About

Jinqian Liu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jinqian Liu has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Jinqian Liu's work include Chemical Synthesis and Analysis (4 papers), Catalytic C–H Functionalization Methods (3 papers) and Biochemical and Molecular Research (3 papers). Jinqian Liu is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Catalytic C–H Functionalization Methods (3 papers) and Biochemical and Molecular Research (3 papers). Jinqian Liu collaborates with scholars based in United States, China and New Zealand. Jinqian Liu's co-authors include Jianjun Yu, Limin Wang, Fenglou Guo, William H. Gmeiner, Ning Jiao, Juan C. Jaén, Nigel P.C. Walker, Jun Qiu, Zhulun Wang and Ying Liu and has published in prestigious journals such as Angewandte Chemie International Edition, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Jinqian Liu

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinqian Liu United States 16 527 386 128 93 91 29 1.1k
Hamish Ryder Spain 20 446 0.8× 528 1.4× 166 1.3× 85 0.9× 244 2.7× 46 1.2k
Kwang Rok Kim South Korea 17 360 0.7× 462 1.2× 62 0.5× 21 0.2× 157 1.7× 29 1.1k
Jianyi Wang China 21 384 0.7× 334 0.9× 93 0.7× 40 0.4× 120 1.3× 86 1.1k
Adnan M.M. Mjalli United States 19 742 1.4× 706 1.8× 85 0.7× 27 0.3× 94 1.0× 36 1.4k
Ya‐Qiu Long China 18 391 0.7× 380 1.0× 41 0.3× 48 0.5× 99 1.1× 51 838
Mark L. Peterson United States 9 554 1.1× 604 1.6× 112 0.9× 67 0.7× 78 0.9× 14 1.0k
Maria Candida Cesta Italy 15 199 0.4× 286 0.7× 40 0.3× 76 0.8× 152 1.7× 35 751
Zengtao Wang China 18 291 0.6× 437 1.1× 60 0.5× 16 0.2× 105 1.2× 83 1.1k
Thomas Harrity United States 17 257 0.5× 611 1.6× 103 0.8× 24 0.3× 177 1.9× 23 1.1k
Jean‐Michel Rondeau Switzerland 23 300 0.6× 843 2.2× 245 1.9× 80 0.9× 259 2.8× 43 1.6k

Countries citing papers authored by Jinqian Liu

Since Specialization
Citations

This map shows the geographic impact of Jinqian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinqian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinqian Liu more than expected).

Fields of papers citing papers by Jinqian Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinqian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinqian Liu. The network helps show where Jinqian Liu may publish in the future.

Co-authorship network of co-authors of Jinqian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinqian Liu. A scholar is included among the top collaborators of Jinqian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinqian Liu. Jinqian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Rui, Yuhui Wang, Shuai Li, et al.. (2024). Insights into the Distinct Behaviors between Bifunctional and Binary Organoborane Catalysts through Terpolymerization of Epoxide, CO2, and Anhydride. Angewandte Chemie International Edition. 63(27). e202404207–e202404207. 11 indexed citations
2.
3.
Liu, Jinqian, Wen Wang, Changqing Wang, et al.. (2022). Discovery of Antibacterial Contezolid Acefosamil: Innovative O-Acyl Phosphoramidate Prodrug for IV and Oral Therapies. ACS Medicinal Chemistry Letters. 13(7). 1030–1035. 13 indexed citations
4.
Wang, Wen, et al.. (2021). Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity. Chemical Research in Toxicology. 34(5). 1348–1354. 25 indexed citations
5.
Ma, Zhihua, Daniel C.-H. Lin, Rajiv Sharma, et al.. (2015). Discovery of the imidazole-derived GPR40 agonist AM-3189. Bioorganic & Medicinal Chemistry Letters. 26(1). 15–20. 16 indexed citations
6.
Zhu, Xiang, et al.. (2015). ATP-sensitive potassium channels alleviate postoperative pain through JNK-dependent MCP-1 expression in spinal cord. International Journal of Molecular Medicine. 35(5). 1257–1265. 9 indexed citations
7.
Zhong, Dafang, Liang Li, Zhengyu Yuan, et al.. (2015). Metabolism of MRX-I, a Novel Antibacterial Oxazolidinone, in Humans: The Oxidative Ring Opening of 2,3-Dihydropyridin-4-One Catalyzed by Non-P450 Enzymes. Drug Metabolism and Disposition. 43(5). 646–659. 44 indexed citations
10.
Fang, Leiming, et al.. (2014). Nickel‐Catalyzed One‐Pot Suzuki–Miyaura Cross‐Coupling of Phenols and Arylboronic Acids Mediated by N,N‐Ditosylaniline. European Journal of Organic Chemistry. 2014(23). 4953–4957. 15 indexed citations
11.
Lizarzaburu, Mike E., Simon Turcotte, Xiaohui Du, et al.. (2012). Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus. Bioorganic & Medicinal Chemistry Letters. 22(18). 5942–5947. 28 indexed citations
12.
Jiao, Xian‐Yun, David J. Kopecky, Jinsong Liu, et al.. (2012). Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(19). 6212–6217. 58 indexed citations
13.
Brown, Sean P., Paul J. Dransfield, Marc Vimolratana, et al.. (2012). Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist. ACS Medicinal Chemistry Letters. 3(9). 726–730. 68 indexed citations
14.
Xiao, Shou-Hua, Ellyn Farrelly, John V. Anzola, et al.. (2007). An ultrasensitive high-throughput electrochemiluminescence immunoassay for the Cdc42-associated protein tyrosine kinase ACK1. Analytical Biochemistry. 367(2). 179–189. 8 indexed citations
15.
Powers, Jay P., Shyun Li, Juan C. Jaén, et al.. (2006). Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorganic & Medicinal Chemistry Letters. 16(11). 2842–2845. 99 indexed citations
16.
Shuttleworth, Stephen, Richard Connors, Jiasheng Fu, et al.. (2005). Design and Synthesis of Protein Superfamily-Targeted Chemical Libraries for Lead Identification and Optimization. Current Medicinal Chemistry. 12(11). 1239–1281. 15 indexed citations
17.
18.
Gmeiner, William H., et al.. (1999). Cytotoxicity and In Vivo Tolerance of FdUMP[10]: A Novel Pro-Drug of the TS Inhibitory Nucleotide FdUMP. Nucleosides and Nucleotides. 18(6-7). 1729–1730. 12 indexed citations
19.
Liu, Jinqian, et al.. (1999). Increased Cytotoxicity and Decreased In Vivo Toxicity of FdUMP[10] Relative to 5-FU. Nucleosides and Nucleotides. 18(8). 1789–1802. 24 indexed citations
20.
Liu, Jinqian, et al.. (1999). Positive Interaction between 5-FU and FdUMP[10] in the Inhibition of Human Colorectal Tumor Cell Proliferation. Antisense and Nucleic Acid Drug Development. 9(5). 481–486. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026